Search citation statements
Paper Sections
Citation Types
Year Published
Publication Types
Relationship
Authors
Journals
Various types of cytogenetic change can be detected in chromosomes, including structural chromosome aberrations, aneuploidy or sister chromatid exchanges. Chromosome aberration assays are used to detect chromosome damage (clastogenesis) in somatic and germinal cells by direct observation during metaphase analysis, or by indirect observation of micronuclei. Aberrations are mostly lethal to the cell during the cell cycle following their induction; they also indicate a potential to induce more subtle and transmissible chromosomal damage which survives cell division, producing heritable cytogenetic changes. Cytogenetic damage is usually accompanied by gene mutation. Structural and numerical abnormalities in somatic cells are involved in the aetiology of neoplasia, while in germ cells they can lead to perinatal mortality, dominant lethality or congenital malformations in the offspring. Over 80% of all structural aberrations in humans occur de novo and are of paternal origin. This chapter addresses the different cytogenetic changes and assays which measure gross chromosomal damage in human somatic and germ cells in vitro and in vivo , as well as regulatory requirements for measuring them. Also to be considered are the growing importance of modern molecular cytogenetics, the Human Genome project and the awakening awareness of epigenetics as a biological concern.
Various types of cytogenetic change can be detected in chromosomes, including structural chromosome aberrations, aneuploidy or sister chromatid exchanges. Chromosome aberration assays are used to detect chromosome damage (clastogenesis) in somatic and germinal cells by direct observation during metaphase analysis, or by indirect observation of micronuclei. Aberrations are mostly lethal to the cell during the cell cycle following their induction; they also indicate a potential to induce more subtle and transmissible chromosomal damage which survives cell division, producing heritable cytogenetic changes. Cytogenetic damage is usually accompanied by gene mutation. Structural and numerical abnormalities in somatic cells are involved in the aetiology of neoplasia, while in germ cells they can lead to perinatal mortality, dominant lethality or congenital malformations in the offspring. Over 80% of all structural aberrations in humans occur de novo and are of paternal origin. This chapter addresses the different cytogenetic changes and assays which measure gross chromosomal damage in human somatic and germ cells in vitro and in vivo , as well as regulatory requirements for measuring them. Also to be considered are the growing importance of modern molecular cytogenetics, the Human Genome project and the awakening awareness of epigenetics as a biological concern.
Chromosome aberration assays are employed to detect the induction of chromosome breakage (clastogenesis) in somatic and germ cells by direct observation of the chromosomal damage during metaphase analysis, or by indirect observation of chromosomal fragments. Thus, various types of cytogenetic change can be detected such as structural chromosome aberrations (CA), sister chromatid exchanges (SCE), ploidy changes, and micronuclei. Following the induction of the chromosomal damage, most of the aberrations and abnormalities detected by these assays can be detrimental or even lethal to the cell. Their presence, however, indicates a potential to also induce more subtle and therefore transmissible chromosomal damage which survives cell division to produce heritable cytogenetic changes. Usually, induced cytogenetic damage is accompanied by other genotoxic damage such as gene mutations.
22In vivo tests for male reproductive genotoxicity are time consuming, resource-23 intensive and their use should be minimised according to the principles of the 3Rs. 24Accordingly, we investigated the effects in vitro, of a variety of known, phase-specific 25 germ cell mutagens, i.e. pre-meiotic, meiotic, and post-meiotic genotoxins, on rat 26 spermatogenic cell types separated using Staput unit-gravity velocity sedimentation, 27 evaluating DNA damage using the Comet assay. N-ethyl-N-nitrosourea (ENU), N-28 methyl-N-nitrosourea (MNU) (spermatogenic phase), 6-mercaptopurine (6-MP) and 29 5-bromo-2'-deoxy-uridine (5-BrdU) (meiotic phase), methyl methanesulphonate 30(MMS) and ethyl methanesulphonate (EMS) (post-meiotic phase) were selected for 31 use as they are potent male rodent, germ cell mutagens in vivo. DNA damage was 32 detected directly using the Comet assay and indirectly using the TUNEL assay. 33Treatment of the isolated cells with ENU and MNU produced the greatest 34 concentration-related increase in DNA damage in spermatogonia. Spermatocytes 35were most sensitive to 6-MP and 5-BrdU while spermatids were particularly 36 susceptible to MMS and EMS. Increases were found when measuring both Olive tail 37 moment (OTM) and % tail DNA, but the greatest changes were in OTM. Parallel 38 results were found with the TUNEL assay, which showed highly significant, (Parodi et al., 2015; Tralau et al., 2012). A particular problem in germ 51 cell mutagenicity studies is the relative lack of suitable tools for detecting mutation 52 induction (Yauk et al., 2015). Historically, studies have utilized huge numbers of 53 animals in assays such as the morphological specific locus (MSL) test (Russell et al., 54 1979) and dominant lethal assay (Anderson et al., 1977), to reveal valuable 55 information about the relative sensitivities male germ cells at different phases of 56 development (phase-specificity). Nevertheless, there is still a general paucity of 57 information on how endogenous factors, for example genetic polymorphisms and 58 exogenous factors such as environmental-toxin exposure, affect the type of germ cell 59 mutations induced and the risk of their induction (Beal et al., 2012). 60In animal tests the rules of the 3 R's: Reduction, Refinement and Replacement 61 (Russell and Burch, 1959), should be applied in planning and performing 62 experiments (Flecknell, 2002). Currently, a variety of alternative animal techniques 63 for assessing the toxicity/genotoxicity of compounds have been developed (Jung et 64 al., 2015; Kandarova and Letasiova, 2011). STAPUT methods require far fewer 65 animals compared with traditional methods thus aiding reduction efforts. Since the 66 animals are not treated, this refines toxicological approaches. Therefore, because 67 the uses of STAPUT combine these advantages, its use in a novel toxicity testing 68 strategy could potentially replace some in vivo testing (Habas et al., 2014). The 69 present study is a first step in testing this idea. 4There is a growing cons...
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
customersupport@researchsolutions.com
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Copyright © 2025 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.